Related Experiment Video
Updated: Aug 4, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study
J Danesh1, L Youngman, S Clark
1Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE. john.danesh@balliol.ox.ac.uk
Insights
Chronic Helicobacter pylori infection shows a moderate association with coronary heart disease. Further large trials are needed to confirm causality and the effects of H. pylori eradication.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Coronary heart disease (CHD) is a leading cause of mortality worldwide.
- The role of chronic infections, such as Helicobacter pylori (H. pylori), as a potential risk factor for CHD is under investigation.
Purpose of the Study:
- To investigate the association between chronic Helicobacter pylori infection and the risk of developing coronary heart disease, specifically early-onset myocardial infarction.
Main Methods:
- A case-control study involving 1122 survivors of myocardial infarction (ages 30-49) and 1122 matched controls.
- A sibling-pair study of 510 pairs where one sibling had myocardial infarction and the other did not.
- Serological testing was used to detect chronic H. pylori infection.
Main Results:
- Individuals with early-onset myocardial infarction had a significantly higher prevalence of H. pylori antibodies (42%) compared to controls (24%), with an initial odds ratio of 2.28.
- The association remained significant after adjusting for smoking, socioeconomic status, lipids, and obesity, with an adjusted odds ratio of 1.75.
- The sibling-pair analysis showed a weaker, non-significant association (odds ratio 1.33).
Conclusions:
- These studies suggest a moderate association between coronary heart disease and H. pylori seropositivity, independent of common risk factors.
- While the association may be causal, large randomized trials are necessary to confirm this and assess the impact of H. pylori eradication.
Objectives:
To examine the association between coronary heart disease and chronic Helicobacter pylori infection.
Design:
Case-control study of myocardial infarction at young ages and study of sibling pairs with one member affected and the other not.
Setting:
United Kingdom.
Participants:
1122 survivors of suspected acute myocardial infarction at ages 30-49 (mean age 44 years) and 1122 age and sex matched controls with no history of coronary heart disease; 510 age and sex matched pairs of siblings (mean age 59 years) in which one sibling had survived myocardial infarction and one had no history of coronary heart disease.
Main Outcome Measures:
Serological evidence of chronic infection with H pylori.
Results:
472 (42%) of the 1122 cases with early onset myocardial infarction were seropositive for H pylori antibodies compared with 272 (24%) of the 1122 age and sex matched controls, giving an odds ratio of 2.28 (99% confidence interval 1.80 to 2.90). This odds ratio fell to 1.87 (1.42 to 2.47; P<0.0001) after smoking and indicators of socioeconomic status were adjusted for and to 1.75 (1.29 to 2.36) after additional adjustment for blood lipid concentrations and obesity. Only 158 of the 510 pairs of siblings were discordant for H pylori status; among these, 91 cases and 67 controls were seropositive (odds ratio 1.33 (0.86 to 2.05)). No strong correlations were observed between H pylori seropositivity and measurements of other risk factors for coronary heart disease (plasma lipids, fibrinogen, C reactive protein, albumin, etc).
Conclusion:
In the context of results from other relevant studies, these two studies suggest a moderate association between coronary heart disease and H pylori seropositivity that cannot be fully accounted for by other risk factors. But even if this association is causal and largely reversible by eradication of chronic infection, very large randomised trials would be needed to show this.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Peptic Ulcer
Gastritis II: Pathophysiology